Sponsor Pipeline

Anocca AB Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07145450 Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen… PDAC Recruiting
Get alerts when Anocca AB's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free